These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3537828)

  • 21. [The multimodal strategy for the neuroprotection in stroke: results of the Russian multicenter clinical-epidemiological program SOKOL].
    Tabeeva GR; Azimova IuE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(12 Pt 2):20-30. PubMed ID: 23388602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Observations with cavinton treatment in acute cerebral ischaemic conditions.
    Kovács G
    Ther Hung; 1984; 32(4):155-7. PubMed ID: 6571201
    [No Abstract]   [Full Text] [Related]  

  • 23. [Implication of vinpotropile in the treatment of patients with cerebral stroke].
    Kuznetsov AN; Daminov VD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; Suppl 21():52-6. PubMed ID: 18927980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Observations with Cavinton (RGH-4405).
    Alberth B; Somogyi E
    Ther Hung; 1979; 27(1):17-27. PubMed ID: 494138
    [No Abstract]   [Full Text] [Related]  

  • 25. [Hemodynamic disorders and various problems in treatment in strokes with reversible neurologic deficits].
    Vinichuk SM; Malyĭ VD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(9):1290-6. PubMed ID: 3776406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of Cavinton on the pathological changes in ischemic brain changes starting as an acute disease].
    Bałuka-Horecka M
    Przegl Lek; 1982; 39(4):325-8. PubMed ID: 7100509
    [No Abstract]   [Full Text] [Related]  

  • 27. [Use of cavinton in epilepsy].
    Dutov AA; Tolpyshev BA; Petrov AP; Gladun VN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(6):850-5. PubMed ID: 3751419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prospects of using cavinton for treating Ménière's disease].
    Nikolaev MP; Konstantinova ZD; Mertsalova ON; Sheremet AS
    Vestn Otorinolaringol; 1980; (3):18-22. PubMed ID: 7385520
    [No Abstract]   [Full Text] [Related]  

  • 29. [Experience with the use of cavinton in the treatment of patients with incipient senile atherosclerotic encephalopathy].
    Man'kovskiĭ NB; Mints AIa; Karaban' IN; Litvinenko AA; Bachinskaia NIu
    Vrach Delo; 1987 Jan; (1):46-9. PubMed ID: 3564418
    [No Abstract]   [Full Text] [Related]  

  • 30. Effectivity of Cavinton and Lucidril in the treatment of hearing defects of different origin.
    Jasper A
    Ther Hung; 1979; 27(1):29-31. PubMed ID: 386551
    [No Abstract]   [Full Text] [Related]  

  • 31. [A differential approach to cavinton and finoptin treatment of patients with circulatory encephalopathies].
    Burtsev EM; Shprakh VV; Savkov VS
    Ross Med Zh; 1992; (2):41-3. PubMed ID: 1643337
    [No Abstract]   [Full Text] [Related]  

  • 32. Study on the vasodilator effects of ethyl apovincaminate in neurosurgical patients.
    Fényes G; Tarjányi J; Ladvánszky C
    Arzneimittelforschung; 1976; 26(10a):1956-62. PubMed ID: 1037223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Therapeutic effect of cavinton in chronic cerebral circulatory insufficiency].
    Burtsev EM; Tugutov AI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(1):53-6. PubMed ID: 3984593
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current treatment of cerebrovascular disorder with vasoactive drugs].
    Lebiediewa NW
    Neurol Neurochir Pol; 1981; 15(4):417-21. PubMed ID: 6895779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of circulatory encephalopathy with Cavinton].
    Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR
    Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of corglycon and cavinton on the hemodynamics of patients with initial manifestations of insufficiency of cerebral circulation].
    Ishchenko MM; Nechaĭ EE
    Vrach Delo; 1988 May; (5):53-5. PubMed ID: 3420871
    [No Abstract]   [Full Text] [Related]  

  • 37. Principles of pharmacologic correction of neurologic disorders in initial atherosclerotic encephalopathy.
    Man'kovsky NB; Minz AY
    Gerontology; 1988; 34(1-2):75-81. PubMed ID: 3384341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rheoencephalographic and psychological studies with ethyl apovincaminate in cerebral vascular insufficiency.
    Hadjiev D; Yancheva S
    Arzneimittelforschung; 1976; 26(10a):1947-50. PubMed ID: 1037222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The evaluation of the efficacy of antihypoxic agents lowering hemoglobin oxygen affinity in acute cerebral ischemia].
    Plotnikova TM; Plotnikov MB; Bazhenova TG
    Biull Eksp Biol Med; 1991 Feb; 111(2):170-2. PubMed ID: 1854961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cavinton treatment of patients with chronic cerebral circulatory insufficiency].
    Ishchenko MM; Shkrobot SI; Ishchenko AM
    Vrach Delo; 1986 Apr; (4):51-4. PubMed ID: 3716339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.